Tevard Biosciences Reports Full Dystrophin Restoration and Titin Rescue with Suppressor tRNA Therapy at ASGCT 2026
Tevard Biosciences presented preclinical data showing its suppressor tRNA therapy achieved complete dystrophin restoration in Duchenne muscular dystrophy models and robust titin rescue in cardiomyopathy models, highlighting the platform's potential for treating nonsense mutation diseases.
